Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis
Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significa...
Saved in:
Published in | Progress in neuro-psychopharmacology & biological psychiatry Vol. 80; no. Pt C; pp. 217 - 226 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Inc
03.01.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.
We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.
Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.
Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies. |
---|---|
AbstractList | Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.
We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.
Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.
Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies. Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.INTRODUCTIONMajor Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system (CNS). This is reflected by elevated plasma levels of inflammatory cytokines in depressed subjects. Although numerous studies report significant influence of antidepressants on pro-inflammatory/anti-inflammatory cytokines balance, the available data is often inconsistent regarding specific cytokines and drugs used. We aimed to perform a comprehensive meta-analysis of the effect of antidepressant treatment on a wide array of cytokines.We performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.METHODSWe performed a systematic search of 6 databases, which yielded 32 studies measuring the levels of selected cytokines before and at a second time-point during antidepressant treatment. For meta-analysis of selected studies with a continuous measure we analysed variables containing the number of cases, mean and standard deviation of the level of IL-1ß, IL-2, IL-5, IL-6, IL-8, IL-10, CRP, TNF-α, IFN-γ levels observed in the different studies, in the intervention groups before and after antidepressant treatment.Statistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.RESULTSStatistical analysis revealed significant decreases of IL-4, IL-6, and IL-10 in MDD subjects after antidepressant treatment. In case of IL-1ß the decrease was significant exclusively for SSRI drugs. We did not find any significant effect of antidepressant medication on IL-2, TNF-α IFN-γ and CRP.Antidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies.CONCLUSIONSAntidepressant treatment affects the levels of cytokines in depression. The immunological imbalance in MDD is complex and seems to be mediated by other factors yet to be elucidated. The credibility of our results is limited by high heterogeneity among studies and very few studies with a placebo-controlled design. Research with MDD subtypes, response to treatment status and cytokine associations with the kynurenine pathway taken into account pose a promising target for future studies. |
Author | Marcinowicz, Piotr Mosiołek, Anna Janus, Marta Szulc, Agata Waszkiewicz, Napoleon Dębowska, Weronika Krupa, Renata Więdłocha, Magdalena Janoska-Jaździk, Marlena |
Author_xml | – sequence: 1 givenname: Magdalena orcidid: 0000-0001-8353-7820 surname: Więdłocha fullname: Więdłocha, Magdalena email: mwiedlocha@wp.pl organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland – sequence: 2 givenname: Piotr surname: Marcinowicz fullname: Marcinowicz, Piotr organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland – sequence: 3 givenname: Renata surname: Krupa fullname: Krupa, Renata organization: Department of Molecular Genetics, Faculty of Biology and Environmental Protection, University of Lodz, Poland – sequence: 4 givenname: Marlena surname: Janoska-Jaździk fullname: Janoska-Jaździk, Marlena organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland – sequence: 5 givenname: Marta surname: Janus fullname: Janus, Marta organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland – sequence: 6 givenname: Weronika surname: Dębowska fullname: Dębowska, Weronika organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland – sequence: 7 givenname: Anna surname: Mosiołek fullname: Mosiołek, Anna organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland – sequence: 8 givenname: Napoleon surname: Waszkiewicz fullname: Waszkiewicz, Napoleon organization: Department of Psychiatry, Faculty of Medicine, Medical University in Bialystok, Poland – sequence: 9 givenname: Agata surname: Szulc fullname: Szulc, Agata organization: Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Poland |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28445690$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kb9u1TAUhy1URG8LT4CEMrIkHDu24wwMVVX-SJVYYGCyHPtY-JI4wfZF6tZ34A15EtzedmHo5J-Oft-RzuczchLXiIS8ptBRoPLdvtviNm0dAzp0wDtg8hnZUTWoljMqT8gOWM1CcXlKznLeAwDtoX9BTpniXMgRduT7lfdoS7P6xsQSHG4Jc66xKQlNWbCmNTYbprD9wGTmJkQ_m2UxJdT5YtJPTLn5e_unuWgWLKY10cw3OeSX5Lk3c8ZXD-85-fbh6uvlp_b6y8fPlxfXreVMlBbH3iqUvfReOcY4DIZbAwwdInMDuDpSXkpnQFgq7KQmwSfwzMtJjNj35-Ttce-W1l8HzEUvIVucZxNxPWRN1cgGJsTIa_XNQ_UwLej0lkI94EY_6qiF8Viwac05odc2lPtLSzJh1hT0nXq91_fq9Z16DVxX9ZXt_2Mf1z9NvT9SWBX9Dph0tgGjRRdS_Rft1vAk_w_OcqBn |
CitedBy_id | crossref_primary_10_1186_s13550_018_0401_9 crossref_primary_10_1016_j_jad_2024_09_172 crossref_primary_10_1016_j_bbih_2021_100232 crossref_primary_10_1016_j_jad_2022_06_080 crossref_primary_10_1016_j_jad_2021_08_126 crossref_primary_10_1016_j_jad_2023_02_064 crossref_primary_10_34067_KID_0000062020 crossref_primary_10_1016_j_brainres_2019_146398 crossref_primary_10_1016_j_euroneuro_2021_11_003 crossref_primary_10_1159_000513093 crossref_primary_10_37376_benunivmedj_v1i1_7141 crossref_primary_10_1097_j_pain_0000000000001997 crossref_primary_10_1007_s10067_022_06455_x crossref_primary_10_1089_jwh_2017_6878 crossref_primary_10_1523_JNEUROSCI_1004_18_2018 crossref_primary_10_1177_0003319718780145 crossref_primary_10_1016_j_jbspin_2021_105200 crossref_primary_10_2147_JIR_S387588 crossref_primary_10_1186_s12889_025_22303_4 crossref_primary_10_1016_j_ypmed_2020_106050 crossref_primary_10_1097_MD_0000000000014419 crossref_primary_10_1186_s40345_019_0152_1 crossref_primary_10_1016_j_jad_2019_02_042 crossref_primary_10_1016_j_biopha_2020_111200 crossref_primary_10_1002_rmv_2417 crossref_primary_10_1016_j_neubiorev_2018_03_023 crossref_primary_10_3389_fpsyt_2021_801738 crossref_primary_10_1016_j_intimp_2023_110108 crossref_primary_10_1016_j_jpsychires_2025_01_036 crossref_primary_10_2174_1570159X20666220627160048 crossref_primary_10_1016_j_bbih_2022_100579 crossref_primary_10_1016_j_neubiorev_2023_105425 crossref_primary_10_3390_ijms24076664 crossref_primary_10_1016_j_bbi_2020_04_013 crossref_primary_10_5114_reum_154905 crossref_primary_10_1007_s00406_021_01245_z crossref_primary_10_1159_000506133 crossref_primary_10_37939_jrmc_v27i4_2343 crossref_primary_10_3390_app142411540 crossref_primary_10_1017_neu_2021_44 crossref_primary_10_22159_ijpps_2022v14i3_43662 crossref_primary_10_1080_15622975_2021_2013095 crossref_primary_10_3389_fgene_2022_865015 crossref_primary_10_1111_cen3_12537 crossref_primary_10_4103_indianjpsychiatry_indianjpsychiatry_380_22 crossref_primary_10_1016_j_brainres_2023_148723 crossref_primary_10_1016_j_bbih_2024_100925 crossref_primary_10_1177_2632010X231180797 crossref_primary_10_1111_bcpt_13385 crossref_primary_10_1007_s00393_018_0568_5 crossref_primary_10_1016_j_pnpbp_2019_01_001 crossref_primary_10_1177_17590914231181037 crossref_primary_10_1177_0269881120936486 crossref_primary_10_3389_fgene_2018_00561 crossref_primary_10_1159_000505275 crossref_primary_10_3390_brainsci14090850 crossref_primary_10_1038_s41398_020_00933_z crossref_primary_10_1186_s12974_022_02429_7 crossref_primary_10_1136_bmjopen_2020_048162 crossref_primary_10_3389_fimmu_2019_01696 crossref_primary_10_3390_biomedicines10081929 crossref_primary_10_1016_j_jpsychires_2019_03_027 crossref_primary_10_3390_ijms20112778 crossref_primary_10_1523_JNEUROSCI_2673_17_2018 crossref_primary_10_1016_j_jpsychires_2021_01_018 crossref_primary_10_1016_j_bbr_2020_113003 crossref_primary_10_1186_s40779_024_00577_w crossref_primary_10_1016_j_psyneuen_2022_105770 crossref_primary_10_1177_20451253211034320 crossref_primary_10_3390_molecules25143207 crossref_primary_10_1080_08964289_2019_1604489 crossref_primary_10_1016_j_bbi_2023_03_025 crossref_primary_10_1016_j_phrs_2024_107322 crossref_primary_10_3389_fpsyt_2023_1163754 crossref_primary_10_1016_j_jad_2022_09_092 crossref_primary_10_1186_s12974_025_03403_9 crossref_primary_10_3390_molecules27113551 crossref_primary_10_1038_s41398_020_00920_4 crossref_primary_10_1016_j_bbi_2020_01_011 crossref_primary_10_1038_s41398_019_0424_7 crossref_primary_10_1080_14737175_2018_1407242 crossref_primary_10_1016_j_joen_2019_07_017 crossref_primary_10_1016_S2215_0366_20_30564_2 crossref_primary_10_2174_1381612826666200406090051 crossref_primary_10_3389_fpsyt_2024_1366942 crossref_primary_10_5114_reum_2022_114352 crossref_primary_10_1016_j_jad_2022_04_038 crossref_primary_10_3389_fnins_2018_00499 crossref_primary_10_1016_j_jad_2020_07_125 crossref_primary_10_3389_fpsyt_2020_00522 crossref_primary_10_3390_endocrines5040035 crossref_primary_10_1016_j_jpsychires_2022_12_032 crossref_primary_10_1038_s41598_020_57967_y crossref_primary_10_1016_j_bbih_2023_100685 crossref_primary_10_3390_genes11091089 crossref_primary_10_1016_j_pnpbp_2021_110343 crossref_primary_10_2139_ssrn_4069176 crossref_primary_10_1371_journal_pone_0269033 crossref_primary_10_1016_j_rhum_2022_04_002 crossref_primary_10_4103_jmedsci_jmedsci_124_23 crossref_primary_10_1016_j_brainresbull_2022_10_021 crossref_primary_10_1093_brain_awaa405 crossref_primary_10_1016_j_jad_2020_01_048 crossref_primary_10_3390_ijms24054772 crossref_primary_10_1016_j_jpsychires_2022_03_004 crossref_primary_10_1016_j_euroneuro_2020_10_005 crossref_primary_10_1016_j_jad_2021_09_022 crossref_primary_10_1016_j_encep_2021_08_002 crossref_primary_10_1038_s41398_019_0521_7 crossref_primary_10_1016_j_jpsychires_2018_12_007 crossref_primary_10_1038_s41584_023_01037_w crossref_primary_10_3390_jcm10081706 crossref_primary_10_1016_j_jad_2018_04_115 crossref_primary_10_1080_14656566_2018_1528230 crossref_primary_10_3389_fnbeh_2023_1282242 crossref_primary_10_1186_s12888_024_05910_0 crossref_primary_10_1016_j_euroneuro_2021_09_006 crossref_primary_10_3389_fphar_2022_874375 crossref_primary_10_1016_j_psychres_2022_114725 crossref_primary_10_33808_clinexphealthsci_824534 crossref_primary_10_3390_ijerph19159573 crossref_primary_10_3390_ijms19010233 crossref_primary_10_1016_j_npbr_2019_07_007 crossref_primary_10_1080_15622975_2021_1961502 crossref_primary_10_1186_s12974_021_02245_5 crossref_primary_10_1017_S1092852919001469 crossref_primary_10_3389_fimmu_2020_00388 crossref_primary_10_1016_j_ejphar_2025_177525 crossref_primary_10_2174_1570159X20666220411101217 crossref_primary_10_1016_j_psyneuen_2021_105200 crossref_primary_10_1038_s41598_024_61865_y crossref_primary_10_1111_eip_12775 crossref_primary_10_1007_s12035_021_02718_x crossref_primary_10_1055_a_1531_4460 crossref_primary_10_3389_fpsyt_2020_00704 crossref_primary_10_1080_14737159_2018_1470927 crossref_primary_10_3389_fimmu_2023_1183115 crossref_primary_10_1016_j_psyneuen_2024_107145 crossref_primary_10_1016_j_lanepe_2024_101166 crossref_primary_10_1038_s41598_024_61523_3 crossref_primary_10_1001_jamapsychiatry_2020_1214 crossref_primary_10_1016_j_bpsgos_2024_100332 crossref_primary_10_1016_j_jagp_2018_07_005 crossref_primary_10_1016_j_canlet_2022_215648 crossref_primary_10_1016_j_phrs_2022_106145 crossref_primary_10_1177_1759720X221111613 crossref_primary_10_3390_jcm11216352 crossref_primary_10_1016_j_brainresbull_2024_111131 crossref_primary_10_3390_ijms23031616 crossref_primary_10_1016_j_pnpbp_2025_111251 crossref_primary_10_3390_jpm11020114 crossref_primary_10_1016_j_bbi_2018_10_012 crossref_primary_10_1016_j_chc_2022_08_012 crossref_primary_10_1016_j_jad_2019_04_088 crossref_primary_10_1053_j_ajkd_2019_09_007 crossref_primary_10_3390_medicines9030022 crossref_primary_10_1038_s41380_022_01819_w crossref_primary_10_1016_j_revmed_2018_07_014 crossref_primary_10_3390_cells8010052 crossref_primary_10_1016_j_bbi_2019_12_017 crossref_primary_10_1016_j_neuron_2020_06_002 crossref_primary_10_1097_BOR_0000000000000597 crossref_primary_10_1016_j_jpsychires_2022_12_009 crossref_primary_10_1016_j_jad_2021_03_036 crossref_primary_10_1007_s11011_019_00432_1 crossref_primary_10_1016_j_bbi_2024_08_054 crossref_primary_10_7759_cureus_62991 crossref_primary_10_1007_s12640_017_9859_x crossref_primary_10_1016_j_jpsychires_2019_10_012 crossref_primary_10_1038_s41398_020_01035_6 crossref_primary_10_1016_j_neuroscience_2020_05_014 |
Cites_doi | 10.1016/j.psyneuen.2012.05.005 10.1017/S1092852900013754 10.1016/j.jad.2012.08.007 10.1016/j.euroneuro.2015.06.007 10.1179/1476830513Y.0000000066 10.1016/j.biopsych.2009.09.033 10.1159/000444220 10.1111/j.1440-1681.2008.05077.x 10.3390/ijms16047796 10.1111/acps.12576 10.1038/npp.2011.132 10.1016/j.pnpbp.2013.09.016 10.1016/S0306-9877(03)00207-X 10.1007/s00213-003-1566-z 10.1016/j.jad.2013.06.004 10.2147/NDT.S16382 10.1016/S0893-133X(99)00134-7 10.1001/jamapsychiatry.2014.1611 10.1007/BF02900219 10.1007/s00213-015-4044-5 10.1016/0197-2456(86)90046-2 10.1007/s00702-011-0668-8 10.1016/j.jpsychires.2016.01.008 10.1016/j.neuint.2007.06.037 10.1016/j.jad.2012.03.033 10.1016/S0893-133X(00)00089-0 10.2174/157015912800604542 10.3109/15622970802573246 10.1016/j.psychres.2016.02.052 10.1016/j.jad.2006.07.013 10.1038/sj.mp.4001032 10.1007/s00213-013-3322-3 10.1097/PSY.0b013e3181f883ce 10.1016/j.euroneuro.2008.08.001 10.1055/s-2002-36390 10.1016/j.psychres.2009.04.013 10.1192/bjp.bp.105.011015 10.1006/cyto.1997.0238 10.1002/hup.2333 10.1007/s004060170058 10.1155/2013/267871 10.1002/art.27304 10.1016/0165-0327(95)00028-L 10.1016/j.jpsychires.2015.04.026 10.1038/npp.2011.277 10.1155/2010/573594 10.1002/hup.717 10.1155/2007/76396 10.1017/S0033291712000128 10.1016/j.pnpbp.2007.09.015 10.1016/j.bbi.2011.07.239 10.1038/mp.2010.52 10.1136/bmj.327.7414.557 10.1002/hup.2525 10.1016/S0924-977X(01)00081-5 10.1016/j.pbb.2012.12.003 10.1111/j.1749-6632.1995.tb32372.x |
ContentType | Journal Article |
Copyright | 2017 Elsevier Inc. Copyright © 2017 Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2017 Elsevier Inc. – notice: Copyright © 2017 Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.pnpbp.2017.04.026 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1878-4216 |
EndPage | 226 |
ExternalDocumentID | 28445690 10_1016_j_pnpbp_2017_04_026 S0278584617300659 |
Genre | Meta-Analysis Journal Article |
GroupedDBID | --- --K --M .~1 0R~ 123 1B1 1RT 1~. 1~5 4.4 457 4G. 5RE 7-5 71M 8P~ 9JM AABNK AACTN AADPK AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AATCM AAXLA AAXUO ABCQJ ABFRF ABIVO ABJNI ABMAC ABYKQ ABZDS ACDAQ ACGFO ACGFS ACIUM ACRLP ADBBV ADEZE AEBSH AEFWE AEKER AENEX AFKWA AFTJW AFXIZ AGHFR AGUBO AGWIK AGYEJ AIEXJ AIKHN AITUG AJBFU AJOXV ALCLG ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ AXJTR BKOJK BLXMC C45 CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FIRID FNPLU FYGXN G-Q GBLVA IHE J1W KOM L7B M2V M34 M41 MO0 MOBAO N9A O-L O9- OAUVE OGGZJ OVD OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SCC SDF SDG SES SSN SSP SSZ T5K TEORI ~G- .GJ 29P 53G 5VS AAQFI AAQXK AATTM AAXKI AAYWO AAYXX ABWVN ABXDB ACRPL ACVFH ADCNI ADMUD ADNMO AEIPS AEUPX AFJKZ AFPUW AGCQF AGQPQ AGRNS AHHHB AIGII AIIUN AKBMS AKRWK AKYEP ANKPU APXCP ASPBG AVWKF AZFZN BNPGV CITATION FEDTE FGOYB G-2 HMQ HMT HVGLF HZ~ R2- SEW SNS SPT SSH WUQ ZGI CGR CUY CVF ECM EIF NPM 7X8 EFKBS |
ID | FETCH-LOGICAL-c425t-e93c8e636ff8d22407a4ca02edee2d70d2408f66da05c15cb8b54b0f2f6b59e33 |
IEDL.DBID | .~1 |
ISSN | 0278-5846 1878-4216 |
IngestDate | Tue Aug 05 11:27:48 EDT 2025 Wed Feb 19 02:41:44 EST 2025 Tue Jul 01 01:50:20 EDT 2025 Thu Apr 24 23:07:14 EDT 2025 Fri Feb 23 02:30:46 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | Pt C |
Keywords | Depression Inflammation Cytokines Antidepressants Meta-analysis |
Language | English |
License | Copyright © 2017 Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c425t-e93c8e636ff8d22407a4ca02edee2d70d2408f66da05c15cb8b54b0f2f6b59e33 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8353-7820 |
PMID | 28445690 |
PQID | 1892725594 |
PQPubID | 23479 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1892725594 pubmed_primary_28445690 crossref_citationtrail_10_1016_j_pnpbp_2017_04_026 crossref_primary_10_1016_j_pnpbp_2017_04_026 elsevier_sciencedirect_doi_10_1016_j_pnpbp_2017_04_026 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-01-03 |
PublicationDateYYYYMMDD | 2018-01-03 |
PublicationDate_xml | – month: 01 year: 2018 text: 2018-01-03 day: 03 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Progress in neuro-psychopharmacology & biological psychiatry |
PublicationTitleAlternate | Prog Neuropsychopharmacol Biol Psychiatry |
PublicationYear | 2018 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Köhler, Benros, Nordentoft, Farkouh, Iyengar, Mors, Krogh (bb0160) 2014; 71 Myint, Kim (bb0210) 2003; 61 Sutcigil, Oktenli, Musabak, Bozkurt, Cansever, Uzun, Sanisoglu, Yesilova, Ozmenler, Ozsahin, Sengul (bb0280) 2007; 2007 Ninan, Shelton, Bao, Guico-Pabia (bb0220) 2014; 48 Brunoni, Machado-Vieira, Zarate, Valiengo, Vieira, Benseñor, Lotufo, Gattaz, Teixeira (bb0025) 2014; 231 Crnković, Buljan, Karlović, Krmek (bb0040) 2012; 51 Myint, Kim, Verkerk, Scharpé, Steinbusch, Leonard (bb0215) 2007; 98 Yoshimura, Hori, Ikenouchi-Sugita, Umene-Nakano, Katsuki, Atake, Nakamura (bb0300) 2013; 28 Dahl, Ormstad, Aass, Sandvik, Malt, Andreassen (bb0045) 2016; 134 Maes, Bosmans, De Jongh, Kenis, Vandoolaeghe, Neels (bb0190) 1997; 9 Chang, Lee, Gean, Lee, Chi, Yang, Lu, Chen (bb0030) 2012; 26 Basterzi, Aydemir, Kisa, Aksaray, Tuzer, Yazici, Göka (bb0010) 2005; 20 Abbasi, Hosseini, Modabbernia, Ashrafi, Akhondzadeh (bb0005) 2012; 141 Lanquillon, Krieg, Bening-Abu-Shach, Vedder (bb0170) 2000; 22 Manoharan, Rajkumar, Shewade, Sundaram, Muthuramalingam, Paul (bb0195) 2016; 31 Strawbridge, Arnone, Danese, Papadopoulos, Herane Vives, Cleare (bb0275) 2015; 25 Hannestad, DellaGioia, Bloch (bb0115) 2011; 36 Hernández, Mendieta, Martínez-Fong, Loría, Moreno, Estrada, Bojalil, Pavón, Hernández, Mendieta, Martínez-Fong, Loría, Moreno, Estrada, Bojalil, Pavón (bb0125) 2008; 18 Eller, Vasar, Shlik, Maron (bb0075) 2008; 32 Shelton, Claiborne, Sidoryk-Wegrzynowicz, Reddy, Aschner, Lewis, Mirnics (bb0265) 2011; 2011 Baumeister, Ciufolini, Mondelli (bb0015) 2016; 233 Hinze-Selch, Schuld, Kraus, Kühn, Uhr, Haack, Pollmächer (bb0145) 2000; 23 World Health Organization (bb0295) 2008 Del Grande da Silva, Wiener, Barbosa, Gonçalves Araujo, Molina, San Martin, Oses, Jansen, Dias de Mattos Souza, Azevedo da Silva (bb0050) 2016; 75 Drevets, Savitz, Trimble (bb0065) 2008; 13 Fornaro, Rocchi, Escelsior, Contini, Martino (bb0090) 2013; 145 Higgins, Thompson, Deeks, Altman (bb0135) 2003; 327 Mikova, Yakimova, Bosmans, Kenis, Maes (bb0205) 2001; 11 Piletz, Halaris, Iqbal, Hoppensteadt, Fareed, Zhu, Sinacore, Devane (bb0240) 2009; 10 Tuglu, Kara, Caliyurt, Vardar, Abay (bb0285) 2003; 170 Fornaro, Martino, Battaglia, Colicchio, Perugi (bb0085) 2011; 7 Chen, Lin, Chen, Mao, Hung (bb0035) 2010; 2010 O'Brien, Scott, Dinan (bb0225) 2006; 188 Sacre, Medghalchi, Gregory, Brennan, Williams (bb0255) 2010; 62 Frommberger, Bauer, Haselbauer, Fräulin, Riemann, Berger (bb0095) 1997; 247 Hiles, Baker, de Malmanche, Attia (bb0140) 2012; 42 Kraus, Haack, Schuld, Hinze-Selch, Koethe, Pollmächer (bb0165) 2002; 35 Schmidt, Schröder, Kirkby, Sander, Suslow, Holdt, Teupser, Hegerl, Himmerich (bb0260) 2016; 239 Dowlati, Herrmann, Swardfager, Liu, Sham, Reim, Lanctôt (bb0060) 2010; 2010 Li, Qi, Chen, Zhang, Yi, Yuan, Wang, Hong, Yu, Cui, Fang (bb0175) 2013; 38 Halaris, Myint, Savant, Meresh, Lim, Guillemin, Hoppensteadt, Fareed, Sinacore (bb0110) 2015; 66-67 Maes, Meltzer, Bosmans, Bergmans, Vandoolaeghe, Ranjan, Desnyder (bb0185) 1995; 34 Mackay, Forrest, Christofides, Bridel, Mitchell, Cowlard, Stone, Darlington (bb0180) 2009; 36 Ohgi, Futamura, Kikuchi, Hashimoto (bb0230) 2013; 103 Hernandez, Mendieta, Pérez-Tapia, Bojalil, Estrada-Garcia, Estrada-Parra, Pavón (bb0130) 2013; 2013 Ranjbar, Shams, Sabetkasaei, M-Shirazi, Rashidkhani, Mostafavi, Bornak, Nasrollahzadeh (bb0245) 2014; 17 Gold, Chrousos (bb0100) 2002; 7 Słuzewska, Rybakowski, Laciak, Mackiewicz, Sobieska, Wiktorowicz (bb0270) 1995; 762 Valkanova, Ebmeier, Allan (bb0290) 2013; 150 Gupta, Gupta, Tripathi, Bhatia, Gupta (bb0105) 2016; 97 Zunszain, Anacker, Cattaneo, Choudhury, Musaelyan, Myint, Thuret, Price, Pariante (bb0305) 2012; 37 Jazayeri, Keshavarz, Tehrani-Doost, Djalali, Hosseini, Amini, Chamari, Djazayery (bb0150) 2010; 178 Benton, Lynch, Dube, Gettes, Tustin, Ping Lai, Metzger, Blume, Douglas, Evans (bb0020) 2010; 72 Kocki, Wnuk, Kloc, Kocki, Owe-Larsson, Urbanska (bb0155) 2012; 119 Elenkov (bb0070) 2008; 52 Olajossy, Olajossy, Potembska, Skoczen, Wnuk, Urbańska (bb0235) 2014; 9 DerSimonian, Laird (bb0055) 1986; 7 Rothermundt, Arolt, Fenker, Gutbrodt, Peters, Kirchner (bb0250) 2001; 251 Martino, Rocchi, Escelsior, Fornaro (bb0200) 2012; 10 Hashimoto (bb0120) 2015; 16 Zunszain (10.1016/j.pnpbp.2017.04.026_bb0305) 2012; 37 Li (10.1016/j.pnpbp.2017.04.026_bb0175) 2013; 38 Frommberger (10.1016/j.pnpbp.2017.04.026_bb0095) 1997; 247 Ohgi (10.1016/j.pnpbp.2017.04.026_bb0230) 2013; 103 Benton (10.1016/j.pnpbp.2017.04.026_bb0020) 2010; 72 Crnković (10.1016/j.pnpbp.2017.04.026_bb0040) 2012; 51 Hernandez (10.1016/j.pnpbp.2017.04.026_bb0130) 2013; 2013 Kocki (10.1016/j.pnpbp.2017.04.026_bb0155) 2012; 119 Maes (10.1016/j.pnpbp.2017.04.026_bb0185) 1995; 34 Myint (10.1016/j.pnpbp.2017.04.026_bb0215) 2007; 98 Köhler (10.1016/j.pnpbp.2017.04.026_bb0160) 2014; 71 Brunoni (10.1016/j.pnpbp.2017.04.026_bb0025) 2014; 231 Gold (10.1016/j.pnpbp.2017.04.026_bb0100) 2002; 7 Chang (10.1016/j.pnpbp.2017.04.026_bb0030) 2012; 26 Chen (10.1016/j.pnpbp.2017.04.026_bb0035) 2010; 2010 Słuzewska (10.1016/j.pnpbp.2017.04.026_bb0270) 1995; 762 Hernández (10.1016/j.pnpbp.2017.04.026_bb0125) 2008; 18 Mikova (10.1016/j.pnpbp.2017.04.026_bb0205) 2001; 11 Elenkov (10.1016/j.pnpbp.2017.04.026_bb0070) 2008; 52 Dowlati (10.1016/j.pnpbp.2017.04.026_bb0060) 2010; 2010 Jazayeri (10.1016/j.pnpbp.2017.04.026_bb0150) 2010; 178 Rothermundt (10.1016/j.pnpbp.2017.04.026_bb0250) 2001; 251 Sutcigil (10.1016/j.pnpbp.2017.04.026_bb0280) 2007; 2007 Ninan (10.1016/j.pnpbp.2017.04.026_bb0220) 2014; 48 Drevets (10.1016/j.pnpbp.2017.04.026_bb0065) 2008; 13 Olajossy (10.1016/j.pnpbp.2017.04.026_bb0235) 2014; 9 Hiles (10.1016/j.pnpbp.2017.04.026_bb0140) 2012; 42 Dahl (10.1016/j.pnpbp.2017.04.026_bb0045) 2016; 134 Eller (10.1016/j.pnpbp.2017.04.026_bb0075) 2008; 32 Piletz (10.1016/j.pnpbp.2017.04.026_bb0240) 2009; 10 Abbasi (10.1016/j.pnpbp.2017.04.026_bb0005) 2012; 141 Baumeister (10.1016/j.pnpbp.2017.04.026_bb0015) 2016; 233 Manoharan (10.1016/j.pnpbp.2017.04.026_bb0195) 2016; 31 Yoshimura (10.1016/j.pnpbp.2017.04.026_bb0300) 2013; 28 Fornaro (10.1016/j.pnpbp.2017.04.026_bb0090) 2013; 145 Sacre (10.1016/j.pnpbp.2017.04.026_bb0255) 2010; 62 Halaris (10.1016/j.pnpbp.2017.04.026_bb0110) 2015; 66-67 Lanquillon (10.1016/j.pnpbp.2017.04.026_bb0170) 2000; 22 Tuglu (10.1016/j.pnpbp.2017.04.026_bb0285) 2003; 170 Kraus (10.1016/j.pnpbp.2017.04.026_bb0165) 2002; 35 Hannestad (10.1016/j.pnpbp.2017.04.026_bb0115) 2011; 36 Ranjbar (10.1016/j.pnpbp.2017.04.026_bb0245) 2014; 17 Fornaro (10.1016/j.pnpbp.2017.04.026_bb0085) 2011; 7 Gupta (10.1016/j.pnpbp.2017.04.026_bb0105) 2016; 97 Schmidt (10.1016/j.pnpbp.2017.04.026_bb0260) 2016; 239 Mackay (10.1016/j.pnpbp.2017.04.026_bb0180) 2009; 36 Shelton (10.1016/j.pnpbp.2017.04.026_bb0265) 2011; 2011 Valkanova (10.1016/j.pnpbp.2017.04.026_bb0290) 2013; 150 O'Brien (10.1016/j.pnpbp.2017.04.026_bb0225) 2006; 188 World Health Organization (10.1016/j.pnpbp.2017.04.026_bb0295) 2008 Martino (10.1016/j.pnpbp.2017.04.026_bb0200) 2012; 10 Del Grande da Silva (10.1016/j.pnpbp.2017.04.026_bb0050) 2016; 75 Maes (10.1016/j.pnpbp.2017.04.026_bb0190) 1997; 9 Strawbridge (10.1016/j.pnpbp.2017.04.026_bb0275) 2015; 25 Hinze-Selch (10.1016/j.pnpbp.2017.04.026_bb0145) 2000; 23 DerSimonian (10.1016/j.pnpbp.2017.04.026_bb0055) 1986; 7 Hashimoto (10.1016/j.pnpbp.2017.04.026_bb0120) 2015; 16 Myint (10.1016/j.pnpbp.2017.04.026_bb0210) 2003; 61 Basterzi (10.1016/j.pnpbp.2017.04.026_bb0010) 2005; 20 Higgins (10.1016/j.pnpbp.2017.04.026_bb0135) 2003; 327 |
References_xml | – volume: 48 start-page: 86 year: 2014 end-page: 91 ident: bb0220 article-title: BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry – volume: 9 start-page: 55 year: 2014 end-page: 61 ident: bb0235 article-title: The level of kynurenic acid and selected cytokines during antidepresssive treatment publication-title: Neuropsychiatria Neuropsychologia – volume: 2011 start-page: 751 year: 2011 end-page: 762 ident: bb0265 article-title: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression publication-title: Mol. Psychiatry – volume: 97 start-page: 184 year: 2016 end-page: 188 ident: bb0105 article-title: Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-α in patients of major depressive disorder with severe depression publication-title: Pharmacology – volume: 22 start-page: 370 year: 2000 end-page: 379 ident: bb0170 article-title: Cytokine production and treatment response in major depressive disorder publication-title: Neuropsychopharmacology – volume: 150 start-page: 736 year: 2013 end-page: 744 ident: bb0290 article-title: CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies publication-title: J. Affect. Disord. – volume: 231 start-page: 1315 year: 2014 end-page: 1323 ident: bb0025 article-title: Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial publication-title: Psychopharmacology – volume: 98 start-page: 143 year: 2007 end-page: 151 ident: bb0215 article-title: Kynurenine pathway in major depression: evidence of impaired neuroprotection publication-title: J. Affect. Disord. – volume: 327 start-page: 557 year: 2003 end-page: 560 ident: bb0135 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ – year: 2008 ident: bb0295 article-title: The Global Burden of Disease 2004 Update – volume: 11 start-page: 203 year: 2001 end-page: 208 ident: bb0205 article-title: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis publication-title: Eur. Neuropsychopharmacol. – volume: 20 start-page: 473 year: 2005 end-page: 476 ident: bb0010 article-title: IL6 levels decrease with SSRI treatment in patients with major depression publication-title: Hum Psychopharmacol. – volume: 239 start-page: 85 year: 2016 end-page: 91 ident: bb0260 article-title: Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression publication-title: Psychiatry Res. – volume: 71 start-page: 1381 year: 2014 end-page: 1391 ident: bb0160 article-title: Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials publication-title: JAMA Psychiatry – volume: 9 start-page: 853 year: 1997 end-page: 858 ident: bb0190 article-title: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression publication-title: Cytokine – volume: 2007 start-page: 76396 year: 2007 ident: bb0280 article-title: Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy publication-title: Clin. Dev. Immunol. – volume: 18 start-page: 917 year: 2008 end-page: 924 ident: bb0125 publication-title: Eur. Neuropsychopharmacol. – volume: 178 start-page: 112 year: 2010 end-page: 115 ident: bb0150 article-title: Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder publication-title: Psychiatry Res. – volume: 7 start-page: 51 year: 2011 end-page: 56 ident: bb0085 article-title: Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation publication-title: Neuropsychiatr. Dis. Treat. – volume: 52 start-page: 40 year: 2008 end-page: 51 ident: bb0070 article-title: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being publication-title: Neurochem. Int. – volume: 61 start-page: 519 year: 2003 end-page: 525 ident: bb0210 article-title: Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression publication-title: Med. Hypotheses – volume: 28 start-page: 466 year: 2013 end-page: 470 ident: bb0300 article-title: Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder publication-title: Hum Psychopharmacol. – volume: 2010 start-page: 446 year: 2010 end-page: 457 ident: bb0060 article-title: A meta-analysis of cytokines in major depression publication-title: Biol. Psychiatry – volume: 13 start-page: 663 year: 2008 end-page: 681 ident: bb0065 article-title: The subgenual anterior cingulate cortex in mood disorders publication-title: CNS Spectr. – volume: 10 start-page: 313 year: 2009 end-page: 323 ident: bb0240 article-title: Pro-inflammatory biomakers in depression: treatment with venlafaxine publication-title: World J. Biol. Psychiatry – volume: 75 start-page: 57 year: 2016 end-page: 64 ident: bb0050 article-title: Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial publication-title: J. Psychiatr. Res. – volume: 16 start-page: 7796 year: 2015 end-page: 7801 ident: bb0120 article-title: Inflammatory biomarkers as differential predictors of antidepressant response publication-title: Int. J. Mol. Sci. – volume: 170 start-page: 429 year: 2003 end-page: 433 ident: bb0285 article-title: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder publication-title: Psychopharmacology – volume: 25 start-page: 1532 year: 2015 end-page: 1543 ident: bb0275 article-title: Inflammation and clinical response to treatment in depression: a meta-analysis publication-title: Eur. Neuropsychopharmacol. – volume: 7 start-page: 177 year: 1986 end-page: 188 ident: bb0055 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials – volume: 103 start-page: 856 year: 2013 end-page: 859 ident: bb0230 article-title: Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration publication-title: Pharmacol. Biochem. Behav. – volume: 17 start-page: 65 year: 2014 end-page: 71 ident: bb0245 article-title: Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression publication-title: Nutr. Neurosci. – volume: 72 start-page: 925 year: 2010 end-page: 932 ident: bb0020 article-title: Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication publication-title: Psychosom. Med. – volume: 134 start-page: 40 year: 2016 end-page: 47 ident: bb0045 article-title: Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels publication-title: Acta Psychiatr. Scand. – volume: 42 start-page: 2015 year: 2012 end-page: 2026 ident: bb0140 article-title: Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis publication-title: Psychol. Med. – volume: 10 start-page: 97 year: 2012 end-page: 123 ident: bb0200 article-title: Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance publication-title: Curr. Neuropharmacol. – volume: 251 start-page: 90 year: 2001 end-page: 97 ident: bb0250 article-title: Different immune patterns in melancholic and non-melancholic major depression publication-title: Eur. Arch. Psychiatry Clin. Neurosci. – volume: 32 start-page: 445 year: 2008 end-page: 450 ident: bb0075 article-title: Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry – volume: 7 start-page: 254 year: 2002 end-page: 275 ident: bb0100 article-title: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states publication-title: Mol. Psychiatry – volume: 141 start-page: 308 year: 2012 end-page: 314 ident: bb0005 article-title: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study publication-title: J. Affect. Disord. – volume: 23 start-page: 13 year: 2000 end-page: 19 ident: bb0145 article-title: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine publication-title: Neuropsychopharmacology – volume: 119 start-page: 235 year: 2012 end-page: 243 ident: bb0155 article-title: New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio publication-title: J. Neural. Transm. (Vienna) – volume: 2010 start-page: 573 year: 2010 end-page: 594 ident: bb0035 article-title: Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males publication-title: Mediat. Inflamm. – volume: 51 start-page: 25 year: 2012 end-page: 33 ident: bb0040 article-title: Connection between inflammatory markers, antidepressants and depression publication-title: Acta Clin. Croat. – volume: 34 start-page: 301 year: 1995 end-page: 309 ident: bb0185 article-title: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression publication-title: J. Affect. Disord. – volume: 188 start-page: 449 year: 2006 end-page: 452 ident: bb0225 article-title: 2006. Antidepressant therapy and C-reactive protein levels publication-title: Br. J. Psychiatry – volume: 38 start-page: 107 year: 2013 end-page: 114 ident: bb0175 article-title: Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study publication-title: Psychoneuroendocrinology – volume: 762 start-page: 474 year: 1995 end-page: 476 ident: bb0270 article-title: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine publication-title: Ann. N. Y. Acad. Sci. – volume: 35 start-page: 220 year: 2002 end-page: 225 ident: bb0165 article-title: Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine publication-title: Pharmacopsychiatry – volume: 247 start-page: 228 year: 1997 end-page: 233 ident: bb0095 article-title: 1997. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission publication-title: Eur. Arch. Psychiatry Clin. Neurosci. – volume: 36 start-page: 2452 year: 2011 end-page: 2459 ident: bb0115 article-title: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis publication-title: Neuropsychopharmacology – volume: 2013 start-page: 267871 year: 2013 ident: bb0130 article-title: Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder publication-title: Clin. Dev. Immunol. – volume: 145 start-page: 300 year: 2013 end-page: 307 ident: bb0090 article-title: Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds publication-title: J. Affect. Disord. – volume: 233 start-page: 1575 year: 2016 end-page: 1589 ident: bb0015 article-title: Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? publication-title: Psychopharmacology – volume: 36 start-page: 425 year: 2009 end-page: 435 ident: bb0180 article-title: Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling publication-title: Clin. Exp. Pharmacol. Physiol. – volume: 37 start-page: 939 year: 2012 end-page: 949 ident: bb0305 article-title: Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis publication-title: Neuropsychopharmacology – volume: 31 start-page: 178 year: 2016 end-page: 184 ident: bb0195 article-title: Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine publication-title: Hum Psychopharmacol. – volume: 62 start-page: 683 year: 2010 end-page: 693 ident: bb0255 article-title: Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors publication-title: Arthritis Rheum. – volume: 26 start-page: 90 year: 2012 end-page: 95 ident: bb0030 article-title: Treatment response and cognitive impairment in major depression: association with C-reactive protein publication-title: Brain Behav. Immun. – volume: 66-67 start-page: 118 year: 2015 end-page: 126 ident: bb0110 article-title: Does escitalopram reduce neurotoxicity in major depression? publication-title: J. Psychiatr. Res. – volume: 38 start-page: 107 issue: 1 year: 2013 ident: 10.1016/j.pnpbp.2017.04.026_bb0175 article-title: Venlafaxine inhibits the upregulation of plasma tumor necrosis factor-alpha (TNF-α) in the Chinese patients with major depressive disorder: a prospective longitudinal study publication-title: Psychoneuroendocrinology doi: 10.1016/j.psyneuen.2012.05.005 – volume: 13 start-page: 663 issue: 8 year: 2008 ident: 10.1016/j.pnpbp.2017.04.026_bb0065 article-title: The subgenual anterior cingulate cortex in mood disorders publication-title: CNS Spectr. doi: 10.1017/S1092852900013754 – volume: 145 start-page: 300 issue: 3 year: 2013 ident: 10.1016/j.pnpbp.2017.04.026_bb0090 article-title: Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2012.08.007 – volume: 25 start-page: 1532 issue: 10 year: 2015 ident: 10.1016/j.pnpbp.2017.04.026_bb0275 article-title: Inflammation and clinical response to treatment in depression: a meta-analysis publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2015.06.007 – volume: 17 start-page: 65 issue: 2 year: 2014 ident: 10.1016/j.pnpbp.2017.04.026_bb0245 article-title: Effects of zinc supplementation on efficacy of antidepressant therapy, inflammatory cytokines, and brain-derived neurotrophic factor in patients with major depression publication-title: Nutr. Neurosci. doi: 10.1179/1476830513Y.0000000066 – volume: 2010 start-page: 446 issue: 67 year: 2010 ident: 10.1016/j.pnpbp.2017.04.026_bb0060 article-title: A meta-analysis of cytokines in major depression publication-title: Biol. Psychiatry doi: 10.1016/j.biopsych.2009.09.033 – volume: 97 start-page: 184 issue: 3–4 year: 2016 ident: 10.1016/j.pnpbp.2017.04.026_bb0105 article-title: Effect of mirtazapine treatment on serum levels of brain-derived neurotrophic factor and tumor necrosis factor-α in patients of major depressive disorder with severe depression publication-title: Pharmacology doi: 10.1159/000444220 – volume: 36 start-page: 425 issue: 4 year: 2009 ident: 10.1016/j.pnpbp.2017.04.026_bb0180 article-title: Kynurenine metabolites and inflammation markers in depressed patients treated with fluoxetine or counselling publication-title: Clin. Exp. Pharmacol. Physiol. doi: 10.1111/j.1440-1681.2008.05077.x – volume: 16 start-page: 7796 issue: 4 year: 2015 ident: 10.1016/j.pnpbp.2017.04.026_bb0120 article-title: Inflammatory biomarkers as differential predictors of antidepressant response publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms16047796 – volume: 134 start-page: 40 issue: 1 year: 2016 ident: 10.1016/j.pnpbp.2017.04.026_bb0045 article-title: Recovery from major depressive disorder episode after non-pharmacological treatment is associated with normalized cytokine levels publication-title: Acta Psychiatr. Scand. doi: 10.1111/acps.12576 – volume: 36 start-page: 2452 issue: 12 year: 2011 ident: 10.1016/j.pnpbp.2017.04.026_bb0115 article-title: The effect of antidepressant medication treatment on serum levels of inflammatory cytokines: a meta-analysis publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.132 – volume: 48 start-page: 86 year: 2014 ident: 10.1016/j.pnpbp.2017.04.026_bb0220 article-title: BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2013.09.016 – volume: 9 start-page: 55 issue: 2 year: 2014 ident: 10.1016/j.pnpbp.2017.04.026_bb0235 article-title: The level of kynurenic acid and selected cytokines during antidepresssive treatment publication-title: Neuropsychiatria Neuropsychologia – volume: 61 start-page: 519 issue: 5–6 year: 2003 ident: 10.1016/j.pnpbp.2017.04.026_bb0210 article-title: Cytokine-serotonin interaction through IDO: a neurodegeneration hypothesis of depression publication-title: Med. Hypotheses doi: 10.1016/S0306-9877(03)00207-X – volume: 170 start-page: 429 issue: 4 year: 2003 ident: 10.1016/j.pnpbp.2017.04.026_bb0285 article-title: Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder publication-title: Psychopharmacology doi: 10.1007/s00213-003-1566-z – volume: 150 start-page: 736 issue: 3 year: 2013 ident: 10.1016/j.pnpbp.2017.04.026_bb0290 article-title: CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2013.06.004 – volume: 7 start-page: 51 year: 2011 ident: 10.1016/j.pnpbp.2017.04.026_bb0085 article-title: Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation publication-title: Neuropsychiatr. Dis. Treat. doi: 10.2147/NDT.S16382 – volume: 22 start-page: 370 issue: 4 year: 2000 ident: 10.1016/j.pnpbp.2017.04.026_bb0170 article-title: Cytokine production and treatment response in major depressive disorder publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(99)00134-7 – volume: 71 start-page: 1381 issue: 12 year: 2014 ident: 10.1016/j.pnpbp.2017.04.026_bb0160 article-title: Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials publication-title: JAMA Psychiatry doi: 10.1001/jamapsychiatry.2014.1611 – volume: 247 start-page: 228 issue: 4 year: 1997 ident: 10.1016/j.pnpbp.2017.04.026_bb0095 article-title: 1997. Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission publication-title: Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/BF02900219 – volume: 233 start-page: 1575 issue: 9 year: 2016 ident: 10.1016/j.pnpbp.2017.04.026_bb0015 article-title: Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment? publication-title: Psychopharmacology doi: 10.1007/s00213-015-4044-5 – volume: 7 start-page: 177 year: 1986 ident: 10.1016/j.pnpbp.2017.04.026_bb0055 article-title: Meta-analysis in clinical trials publication-title: Control. Clin. Trials doi: 10.1016/0197-2456(86)90046-2 – volume: 119 start-page: 235 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0155 article-title: New insight into the antidepressants action: modulation of kynurenine pathway by increasing the kynurenic acid/3-hydroxykynurenine ratio publication-title: J. Neural. Transm. (Vienna) doi: 10.1007/s00702-011-0668-8 – volume: 75 start-page: 57 year: 2016 ident: 10.1016/j.pnpbp.2017.04.026_bb0050 article-title: Pro-inflammatory cytokines and psychotherapy in depression: Results from a randomized clinical trial publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2016.01.008 – volume: 52 start-page: 40 issue: 1-2 year: 2008 ident: 10.1016/j.pnpbp.2017.04.026_bb0070 article-title: Neurohormonal-cytokine interactions: implications for inflammation, common human diseases and well-being publication-title: Neurochem. Int. doi: 10.1016/j.neuint.2007.06.037 – volume: 141 start-page: 308 issue: 2–3 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0005 article-title: Effect of celecoxib add-on treatment on symptoms and serum IL-6 concentrations in patients with major depressive disorder: randomized double-blind placebo-controlled study publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2012.03.033 – volume: 23 start-page: 13 issue: 1 year: 2000 ident: 10.1016/j.pnpbp.2017.04.026_bb0145 article-title: Effects of antidepressants on weight and on the plasma levels of leptin, TNF-alpha and soluble TNF receptors: a longitudinal study in patients treated with amitriptyline or paroxetine publication-title: Neuropsychopharmacology doi: 10.1016/S0893-133X(00)00089-0 – volume: 10 start-page: 97 issue: 2 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0200 article-title: Immunomodulation mechanism of antidepressants: interactions between serotonin/norepinephrine balance and Th1/Th2 balance publication-title: Curr. Neuropharmacol. doi: 10.2174/157015912800604542 – volume: 10 start-page: 313 issue: 4 year: 2009 ident: 10.1016/j.pnpbp.2017.04.026_bb0240 article-title: Pro-inflammatory biomakers in depression: treatment with venlafaxine publication-title: World J. Biol. Psychiatry doi: 10.3109/15622970802573246 – volume: 239 start-page: 85 year: 2016 ident: 10.1016/j.pnpbp.2017.04.026_bb0260 article-title: Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2016.02.052 – volume: 98 start-page: 143 issue: 1–2 year: 2007 ident: 10.1016/j.pnpbp.2017.04.026_bb0215 article-title: Kynurenine pathway in major depression: evidence of impaired neuroprotection publication-title: J. Affect. Disord. doi: 10.1016/j.jad.2006.07.013 – volume: 7 start-page: 254 issue: 3 year: 2002 ident: 10.1016/j.pnpbp.2017.04.026_bb0100 article-title: Organization of the stress system and its dysregulation in melancholic and atypical depression: high vs low CRH/NE states publication-title: Mol. Psychiatry doi: 10.1038/sj.mp.4001032 – volume: 231 start-page: 1315 issue: 7 year: 2014 ident: 10.1016/j.pnpbp.2017.04.026_bb0025 article-title: Cytokines plasma levels during antidepressant treatment with sertraline and transcranial direct current stimulation (tDCS): results from a factorial, randomized, controlled trial publication-title: Psychopharmacology doi: 10.1007/s00213-013-3322-3 – volume: 72 start-page: 925 issue: 9 year: 2010 ident: 10.1016/j.pnpbp.2017.04.026_bb0020 article-title: Selective serotonin reuptake inhibitor suppression of HIV infectivity and replication publication-title: Psychosom. Med. doi: 10.1097/PSY.0b013e3181f883ce – volume: 18 start-page: 917 issue: 12 year: 2008 ident: 10.1016/j.pnpbp.2017.04.026_bb0125 publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/j.euroneuro.2008.08.001 – volume: 35 start-page: 220 issue: 6 year: 2002 ident: 10.1016/j.pnpbp.2017.04.026_bb0165 article-title: Body weight, the tumor necrosis factor system, and leptin production during treatment with mirtazapine or venlafaxine publication-title: Pharmacopsychiatry doi: 10.1055/s-2002-36390 – volume: 178 start-page: 112 issue: 1 year: 2010 ident: 10.1016/j.pnpbp.2017.04.026_bb0150 article-title: Effects of eicosapentaenoic acid and fluoxetine on plasma cortisol, serum interleukin-1beta and interleukin-6 concentrations in patients with major depressive disorder publication-title: Psychiatry Res. doi: 10.1016/j.psychres.2009.04.013 – volume: 188 start-page: 449 year: 2006 ident: 10.1016/j.pnpbp.2017.04.026_bb0225 article-title: 2006. Antidepressant therapy and C-reactive protein levels publication-title: Br. J. Psychiatry doi: 10.1192/bjp.bp.105.011015 – volume: 9 start-page: 853 issue: 11 year: 1997 ident: 10.1016/j.pnpbp.2017.04.026_bb0190 article-title: Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression publication-title: Cytokine doi: 10.1006/cyto.1997.0238 – volume: 28 start-page: 466 issue: 5 year: 2013 ident: 10.1016/j.pnpbp.2017.04.026_bb0300 article-title: Plasma levels of interleukin-6 and selective serotonin reuptake inhibitor response in patients with major depressive disorder publication-title: Hum Psychopharmacol. doi: 10.1002/hup.2333 – volume: 251 start-page: 90 year: 2001 ident: 10.1016/j.pnpbp.2017.04.026_bb0250 article-title: Different immune patterns in melancholic and non-melancholic major depression publication-title: Eur. Arch. Psychiatry Clin. Neurosci. doi: 10.1007/s004060170058 – volume: 2013 start-page: 267871 year: 2013 ident: 10.1016/j.pnpbp.2017.04.026_bb0130 article-title: Effect of selective serotonin reuptake inhibitors and immunomodulator on cytokines levels: an alternative therapy for patients with major depressive disorder publication-title: Clin. Dev. Immunol. doi: 10.1155/2013/267871 – volume: 62 start-page: 683 issue: 3 year: 2010 ident: 10.1016/j.pnpbp.2017.04.026_bb0255 article-title: Fluoxetine and citalopram exhibit potent antiinflammatory activity in human and murine models of rheumatoid arthritis and inhibit toll-like receptors publication-title: Arthritis Rheum. doi: 10.1002/art.27304 – volume: 34 start-page: 301 issue: 4 year: 1995 ident: 10.1016/j.pnpbp.2017.04.026_bb0185 article-title: Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression publication-title: J. Affect. Disord. doi: 10.1016/0165-0327(95)00028-L – volume: 66-67 start-page: 118 year: 2015 ident: 10.1016/j.pnpbp.2017.04.026_bb0110 article-title: Does escitalopram reduce neurotoxicity in major depression? publication-title: J. Psychiatr. Res. doi: 10.1016/j.jpsychires.2015.04.026 – volume: 37 start-page: 939 issue: 4 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0305 article-title: Interleukin-1β: a new regulator of the kynurenine pathway affecting human hippocampal neurogenesis publication-title: Neuropsychopharmacology doi: 10.1038/npp.2011.277 – volume: 2010 start-page: 573 year: 2010 ident: 10.1016/j.pnpbp.2017.04.026_bb0035 article-title: Antidepressant effects on insulin sensitivity and proinflammatory cytokines in the depressed males publication-title: Mediat. Inflamm. doi: 10.1155/2010/573594 – volume: 20 start-page: 473 issue: 7 year: 2005 ident: 10.1016/j.pnpbp.2017.04.026_bb0010 article-title: IL6 levels decrease with SSRI treatment in patients with major depression publication-title: Hum Psychopharmacol. doi: 10.1002/hup.717 – volume: 2007 start-page: 76396 year: 2007 ident: 10.1016/j.pnpbp.2017.04.026_bb0280 article-title: Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy publication-title: Clin. Dev. Immunol. doi: 10.1155/2007/76396 – volume: 42 start-page: 2015 issue: 10 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0140 article-title: Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: a meta-analysis publication-title: Psychol. Med. doi: 10.1017/S0033291712000128 – volume: 32 start-page: 445 issue: 2 year: 2008 ident: 10.1016/j.pnpbp.2017.04.026_bb0075 article-title: Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder publication-title: Prog. Neuro-Psychopharmacol. Biol. Psychiatry doi: 10.1016/j.pnpbp.2007.09.015 – year: 2008 ident: 10.1016/j.pnpbp.2017.04.026_bb0295 – volume: 26 start-page: 90 issue: 1 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0030 article-title: Treatment response and cognitive impairment in major depression: association with C-reactive protein publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2011.07.239 – volume: 2011 start-page: 751 issue: 16 year: 2011 ident: 10.1016/j.pnpbp.2017.04.026_bb0265 article-title: Altered expression of genes involved in inflammation and apoptosis in frontal cortex in major depression publication-title: Mol. Psychiatry doi: 10.1038/mp.2010.52 – volume: 327 start-page: 557 year: 2003 ident: 10.1016/j.pnpbp.2017.04.026_bb0135 article-title: Measuring inconsistency in meta-analyses publication-title: BMJ doi: 10.1136/bmj.327.7414.557 – volume: 31 start-page: 178 issue: 3 year: 2016 ident: 10.1016/j.pnpbp.2017.04.026_bb0195 article-title: Evaluation of interleukin-6 and serotonin as biomarkers to predict response to fluoxetine publication-title: Hum Psychopharmacol. doi: 10.1002/hup.2525 – volume: 51 start-page: 25 issue: 1 year: 2012 ident: 10.1016/j.pnpbp.2017.04.026_bb0040 article-title: Connection between inflammatory markers, antidepressants and depression publication-title: Acta Clin. Croat. – volume: 11 start-page: 203 issue: 3 year: 2001 ident: 10.1016/j.pnpbp.2017.04.026_bb0205 article-title: Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis publication-title: Eur. Neuropsychopharmacol. doi: 10.1016/S0924-977X(01)00081-5 – volume: 103 start-page: 856 year: 2013 ident: 10.1016/j.pnpbp.2017.04.026_bb0230 article-title: Effects of antidepressants on alternations in serum cytokines and depressive-like behavior in mice after lipopolysaccharide administration publication-title: Pharmacol. Biochem. Behav. doi: 10.1016/j.pbb.2012.12.003 – volume: 762 start-page: 474 year: 1995 ident: 10.1016/j.pnpbp.2017.04.026_bb0270 article-title: Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.1995.tb32372.x |
SSID | ssj0001303 |
Score | 2.5809426 |
SecondaryResourceType | review_article |
Snippet | Major Depressive Disorder (MDD) in accordance to the inflammatory concept is associated with complex immunological disturbances in the central nervous system... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 217 |
SubjectTerms | Antidepressants Antidepressive Agents - pharmacology Antidepressive Agents - therapeutic use Biomarkers - blood Cytokines Cytokines - blood Depression Depressive Disorder, Major - blood Depressive Disorder, Major - drug therapy Depressive Disorder, Major - immunology Female Humans Inflammation Inflammation Mediators - blood Male Meta-analysis |
Title | Effect of antidepressant treatment on peripheral inflammation markers – A meta-analysis |
URI | https://dx.doi.org/10.1016/j.pnpbp.2017.04.026 https://www.ncbi.nlm.nih.gov/pubmed/28445690 https://www.proquest.com/docview/1892725594 |
Volume | 80 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1LS8QwEICD6MWL-HZ9EUE8bd0-0kl6XERZFUVQQU-heRRWtLu468GL-B_8h_4SM2m7i6AevLWloSUzmZkkM18I2VcqMy5S0IGJCxMwG2WBEGADmzGmwc2DlMc1XVxC75ad3aV3M-SoqYXBtMra9lc23Vvr-kmn7s3OsN_vXOOeGbrPCJHrkGIRH2MctfzwbZrmgTbar7NwrDBi0JCHfI7XsBwqhFZG3PNOkbDws3f6Lfr0XuhkkSzU4SPtVn-4RGZsuUwOrir-9Gub3kzLqUZtekCvpmTq1xVyX7GK6aCgrkP7dRasu6STfHM6KCnCjz1t4JE6_XMqU5U30idM5Xke0c_3D9qlT3acB3nNNFkltyfHN0e9oD5bIdBulI6dLBItLCRQFML4aV3OdB7G1lgbGx4aRJ8VACYPUx2lWgmVMhUWcQEqzWySrJHZclDaDUJ5AoIJy0GDYpkGEUW54QoUD7MYjGqRuOlTqWvwOJ5_8SibDLMH6QUhURAyZNIJokXak0bDirvx9-vQCEt-Ux_pPMPfDfca0Uo3sHC3JC_t4GUkI5HFHCdcrEXWK5lP_sT5dBd4ZuHmfz-7RebdnfBrOck2mR0_v9gdF92M1a5X310y1z09711-AWVi-1o |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3NTtwwEIBHdDnQSwVtoQuUulLFaaPNjzOxjytUtBRYIXWR4GTFP5EWQXbFLgduvANvyJNgO84ipMKhtyiJlcgznhnbM58BfknJtY0UVKTTSkfUJDxiDE1kOKUK7TxIelzT6QiH5_TPRX6xAgdtLYxLqwy2v7Hp3lqHO_3Qm_3ZZNL_6_bMnPtMHHIdc_4BVh2dKu_A6uDoeDhaGmRnpv1SS-GKjCi28CGf5jWrZ9JxK5PCI08dZOHfDuqtANQ7osN1-BQiSDJofnIDVkz9GfbPGgT1fY-MXyqq5j2yT85e4NT3X-CywRWTaUVsn05CIqy9JMuUczKtieMfe-DANbEqaLWmqXAkNy6b53ZOnh4eyYDcmEUZlQFr8hXOD3-PD4ZROF4hUnagLqw4MsUMZlhVTPuZXUlVGadGG5PqItaOflYh6jLOVZIryWROZVylFcqcmyzbhE49rc03IEWGjDJToEJJuUKWJKUuJMoi5ilq2YW07VOhAnvcHYFxLdoksyvhBSGcIERMhRVEF3rLRrMGvfH-69gKS7zSIGGdw_sNf7aiFXZsuQ2TsjbTu7lIGE8LN-eiXdhqZL78E-vWbezJ4-3__ewPWBuOT0_EydHoeAc-2ifML-1ku9BZ3N6Z7zbYWci9oMzP-z3-Cw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+antidepressant+treatment+on+peripheral+inflammation+markers+%E2%80%93+A+meta-analysis&rft.jtitle=Progress+in+neuro-psychopharmacology+%26+biological+psychiatry&rft.au=Wi%C4%99d%C5%82ocha%2C+Magdalena&rft.au=Marcinowicz%2C+Piotr&rft.au=Krupa%2C+Renata&rft.au=Janoska-Ja%C5%BAdzik%2C+Marlena&rft.date=2018-01-03&rft.issn=0278-5846&rft.volume=80&rft.spage=217&rft.epage=226&rft_id=info:doi/10.1016%2Fj.pnpbp.2017.04.026&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_pnpbp_2017_04_026 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0278-5846&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0278-5846&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0278-5846&client=summon |